List of publications of Gianluca Bontempi
Peer-reviewed journal articles (156)
108.
Desmedt, C., Haibe-Kains, B., Wirapati, P., Buyse, M., Larsimont, D., Bontempi, G., Delorenzi, M., Piccart-Gebhart, M., & Sotiriou, C. (2008). Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clinical cancer research, 14(16), 5158-5165. doi:10.1158/1078-0432.CCR-07-4756109.
Kandil, F. F., Bejjani, G. G., Caelen, O., Bontempi, G., Engelman, E., & Barvais, L. (2008). The efficacy of the semi-automated closed-loop propofol-remifentanil effect-site versus manual TCI anaesthesia. Acta Anaesthesiologica Belgica, 59(2), 113.112.
Le Mercier, M., Lefranc, F., Mijatovic, T., Debeir, O., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Kiss, R., & Mathieu, V. (2008). Evidence of galectin-1 involvement in glioma chemoresistance. Toxicology and applied pharmacology, 229(2), 172-183. doi:10.1016/j.taap.2008.01.009113.
Mijatovic, T., Mahieu, T., Bruyère, C., De Nève, N., Dewelle, J., Simon, G., Dehoux, M., van der Aar, E., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Van Quaquebeke, E., Darro, F., & Kiss, R. (2008). UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia (New York, N.Y.), 10(6), 573-586. doi:10.1593/neo.08290114.
Le Mercier, M., Mathieu, V., Haibe-Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Kiss, R., & Lefranc, F. (2008). Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. Journal of neuropathology and experimental neurology, 67(5), 456-469. doi:10.1097/NEN.0b013e318170f892115.
Mijatovic, T., De Nève, N., Gailly, P., Mathieu, V., Haibe-Kains, B., Bontempi, G., Lapeira, J., Decaestecker, C., Facchini, V., & Kiss, R. (2008). Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Molecular cancer therapeutics, 7(5), 1285-1296. doi:10.1158/1535-7163.MCT-07-2241